Erlend Petter Skagseth • 1955 • Paradis • 8 roles • 4 shareholdings

This website uses cookies to enhance the user experience.

||

Roles

Management

Name	Role	Total operating income	Total equity	Shares
S SARSIA SEED AS	Managing Director/CEO	-	8,817,540	3.25 % indirectly

Boards

Name	Role	Total operating income	Total equity	Shares
M MITOSIS AS	Chairman	-	5,747,560	100 % directly
R RECCURA THERAPEUTICS AS	Chairman	-	56,147	-
S SERCA PHARMACEUTICALS AS	Chairman	2,962,524	27,895,940	-
A AVEXXIN ONCOLOGY AS Closed	Chairman	-	-78,133	-
A APIM THERAPEUTICS AS	Chairman	-	-	-
B BOLIGSAMEIET ST. OLAVS VEI 25	Board Member	-	-	-
C CAEDO ONCOLOGY AS	Chairman	1,836,881	34,536,141	-

Last update: Dec 10, 2025

Related industries

3

Industry and manufacturing
Process industry
Services
Research
Goods and trade
Purchase and sale

Direct relationships

5

JR
John Robert Zibert1977
RECCURA THERAPEUTICS AS, AVEXXIN ONCOLOGY AS
KH
Kjetil Hestdal1960
SERCA PHARMACEUTICALS AS, CAEDO ONCOLOGY AS
SH
Sveinung Hole1967
SARSIA SEED AS
JH
Jon Hindar1956
CAEDO ONCOLOGY AS
OJ
Ole Jesper Dahlberg1971
CAEDO ONCOLOGY AS

Shares owned by Erlend Petter Skagseth

Name	Share class	Total operating income	Total equity	Share
M MITOSIS AS	Ordinære aksjer	0	5,747,560	100 % directly
S SARSIA MANAGEMENT AS		23,767,700	10,133,140	15.77 % indirectly
S SARSIA IV AS		0	-64,167	15.77 % indirectly
S SARSIA SEED AS		0	8,817,540	3.25 % indirectly

Limited to direct ownership positions of 0.5% or more.

Last update: Jun 2, 2025